Literature DB >> 2199344

Free radical generation by redox cycling of estrogens.

J G Liehr1, D Roy.   

Abstract

Natural and synthetic estrogens elicit normal hormonal responses in concentrations in a clearly defined yet low range. At elevated doses, metabolic reactions of the phenolic moiety, while harmless at low levels, may become the predominant biochemical activity and may exert deleterious effects. These metabolic pathways, such as i) oxidation of estrogens to catechol estrogens and further to their respective quinones, and ii) free radical generation by redox cycling between catechol estrogens or diethylstilbestrol and their quinones, are investigated for their influence in physiological or pathophysiological processes. In this review, the in vitro capacity of various enzymes to oxidize estrogen hydroquinones to quinones or to reduce corresponding quinones to hydroquinones is evaluated. The in vivo activities of enzymes supporting redox cycling of estrogens and free radical generation is correlated with induction of kidney tumors in Syrian hamsters. Concomitant changes in activities in quinone reductase and other detoxifying enzymes in kidneys of hamsters treated with estrogen support a role of free radicals in the induction of tumors by estrogen. Free radical damage to protein and possibly to DNA in kidneys of estrogen-treated hamsters may be used as markers of free radical action in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199344     DOI: 10.1016/0891-5849(90)90108-u

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  36 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Nimee K Bhat; Hari K Bhat
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

Review 3.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

4.  Dopamine-dependent cognitive processes after menopause: the relationship between COMT genotype, estradiol, and working memory.

Authors:  Julie A Dumas; Jenna A Makarewicz; Janice Bunn; Joshua Nickerson; Elizabeth McGee
Journal:  Neurobiol Aging       Date:  2018-08-16       Impact factor: 4.673

5.  Structural determinant of chemical reactivity and potential health effects of quinones from natural products.

Authors:  Tingting Tu; Daryl Giblin; Michael L Gross
Journal:  Chem Res Toxicol       Date:  2011-08-02       Impact factor: 3.739

Review 6.  Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity.

Authors:  Michelle C Sangar; Seema Bansal; Narayan G Avadhani
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

7.  Diallyl sulfide inhibits diethylstilbestrol induced DNA damage in human breast epithelial cells (MCF-10A).

Authors:  Michael L McCaskill; Eleanor Rogan; Ronald D Thomas
Journal:  Steroids       Date:  2014-09-30       Impact factor: 2.668

8.  4-Hydroxylation of estrogens as marker of human mammary tumors.

Authors:  J G Liehr; M J Ricci
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 9.  Cellular iron metabolism in prognosis and therapy of breast cancer.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Crit Rev Oncog       Date:  2013

10.  Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction.

Authors:  Fritz F Parl; Kathleen M Egan; Chun Li; Philip S Crooke
Journal:  Cancer Inform       Date:  2009-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.